The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Atea Pharmaceuticals Inc. (AVIR) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.02, or 0.41%, to $4.95. The Atea Pharmaceuticals Inc. has recorded 198,656 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Atea Pharmaceuticals Confirms Receipt of Unsolicited Proposal from Tang Capital Partners’ Affiliate, Concentra Biosciences.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Atea Pharmaceuticals Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $4.93 and fluctuated between $5.1600 as its day high and $4.8450 as its day low. The current market capitalization of Atea Pharmaceuticals Inc. is $398.94M. A total of 2.57 million shares were traded on the day, compared to an average of 702.80K shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, AVIR has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 2 SELLs from insiders. Insiders purchased 0 shares during that period but sold 41,666.
In the most recent transaction, BERGER FRANKLIN M sold 16,166 shares of AVIR for 5.16 per share on Nov 14. After the transaction, the Director now owns 778,353 company shares. In a previous transaction on Nov 11, BERGER FRANKLIN M sold 25,500 shares at 5.15 per share. AVIR shares that Director owns now total 794,519.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for AVIR in the last 3 months, the mean price target is $5.33 with high estimates of $8.00 and low estimates of $4.00. In terms of 52-week highs and lows, AVIR has a high of $9.79 and a low of $2.94.
As of this writing, AVIR has an earnings estimate of -$0.47 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of -$0.42 per share and a lower estimate of -$0.55. The company reported an EPS of -$0.41 in the last quarter, which was 8.90% higher than expectations of -$0.45.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. AVIR’s latest balance sheet shows that the firm has $764.38M in Cash & Short Term Investments as of fiscal 2021. Its Book Value Per Share was $7.42, while its Total Shareholder’s Equity was $710.08M.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AVIR is Buy with a score of 3.25.